Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT

被引:21
|
作者
Kunz, Wolfgang G. [1 ]
Eschbach, Ralf S. [1 ]
Stahl, Robert [1 ]
Kazmierczak, Philipp M. [1 ]
Bartenstein, Peter [2 ]
Rominger, Axel [2 ]
Auernhammer, Christoph J. [3 ,4 ,5 ]
Spitzweg, Christine [3 ,4 ,5 ]
Ricke, Jens [1 ]
Cyran, Clemens C. [1 ,4 ,5 ]
机构
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiol, Marchioninistr 15, D-81377 Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Munich, Germany
[3] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Internal Med 4, Munich, Germany
[4] Ludwig Maximilians Univ Munchen, Univ Hosp, Comprehens Canc Ctr CCC LMU, Munich, Germany
[5] Ludwig Maximilians Univ Munchen, Univ Hosp, Interdisciplinary Ctr Neuroendocrine Tumors Gastr, Munich, Germany
来源
CANCER IMAGING | 2018年 / 18卷
关键词
Myocardium; Neuroendocrine tumors; Positron-emission tomography; Multidetector computed tomography; CARCINOID HEART-DISEASE; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; GUIDELINES; MANAGEMENT;
D O I
10.1186/s40644-018-0168-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Focal 68Ga-DOTATATE PET lesions within the myocardium of neuroendocrine tumor (NET) patients are observed in clinical practice. We determined the frequency and characteristics of lesions that are consistent with cardiac metastasis and assessed the lesion detection rate of conventional imaging. Methods: 629 patients who underwent 68Ga-DOTATATE PET-CT at a supraregional comprehensive cancer center on NET were included from a consecutive registry. Inclusion criteria were: (1) focal 68Ga-DOTATATE tracer uptake within the myocardium in more than two sequential PET exams, and (2) contrast-enhanced CT. To determine the diagnostic accuracy of conventional CT imaging, a case-control cohort with a ratio of 1:3 was used. PET and CT were independently analyzed by two blinded readers. Cohen's K was assessed for interreader agreement Descriptive statistics were applied for frequencies and characteristics and group comparisons were analyzed using the Fisher's exact test. Results: The prevalence of myocardial metastases related to the registry was 2.4% (15 of 629 NET patients fulfilling the inclusion criteria), for a total of 21 myocardial 68Ga-DOTATATE foci detected. Myocardial lesions were most frequently located in the left ventricle (43%) and the septum (43%). No patient demonstrated a pericardial effusion. Patients with myocardial metastases did not differ in demographics, tumor grading, disease stage or circulating tumor markers compared to the overall registry (all p > 0.05). Higher Ki67-Indices were observed (p = 0.049) for patients with myocardial metastases. Interreader agreement for PET assessment was excellent (Cohen's K = 1.0). CT reading showed a sensitivity of 19% (95% confidence interval: 6-43%) at a specificity of 100% (95% confidence interval: 90-100%). Conclusions: 68Ga-DOTATATE PET enables detection of myocardial metastatic lesions in NET patients. In contrast, standard morphologic CT imaging provides very limited sensitivity.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
    Wolfgang G. Kunz
    Ralf S. Eschbach
    Robert Stahl
    Philipp M. Kazmierczak
    Peter Bartenstein
    Axel Rominger
    Christoph J. Auernhammer
    Christine Spitzweg
    Jens Ricke
    Clemens C. Cyran
    Cancer Imaging, 18
  • [2] Brain Metastases of a Neuroendocrine Tumor Visualized by 68Ga-DOTATATE PET/CT
    Hoberueck, Sebastian
    Michler, Enrico
    Zoephel, Klaus
    Platzek, Ivan
    Kotzerke, Joerg
    Brogsitter, Claudia
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (01) : 50 - 52
  • [3] 68Ga-DOTATATE PET/CT in Primary Hepatic Neuroendocrine Tumor
    Gorla, Arun Kumar Reddy
    Basher, Rajender Kumar
    Kaman, Lileshwar
    Bal, Amanjit
    Bhattacharya, Anish
    Mittal, Bhagwant Rai
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (02) : 118 - 120
  • [4] Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT
    Sanli, Yasemin
    Garg, Ishan
    Kandathil, Asha
    Kendi, Tuba
    Zanetti, Maria J. Baladron
    Kuyumcu, Serkan
    Subramaniam, Rathan M.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2018, 211 (02) : 267 - 277
  • [5] Neuroendocrine Tumor Recurrence: Diagnosis with 68Ga-DOTATATE PET/CT
    Haug, Alexander R.
    Cindea-Drimus, Ramona
    Auernhammer, Christoph J.
    Reincke, Martin
    Beuschlein, Felix
    Waengler, Bjoern
    Uebleis, Christopher
    Schmidt, Gerwin P.
    Spitzweg, Christine
    Bartenstein, Peter
    Hacker, Marcus
    RADIOLOGY, 2014, 270 (02) : 517 - 525
  • [6] Myocardial, Retro-orbital, and Bilateral Testicular Metastases of an Ileal Neuroendocrine Tumor in 68Ga-DOTATATE PET/CT
    Rogeau, Antoine
    Kaplar, Zoltan
    Fraioli, Francesco
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (02) : 182 - 184
  • [7] The significance of incidental brain uptake on 68Ga-DOTATATE PET-CT in neuroendocrine tumour patients
    Cleary, Jon O.
    Yeung, Jason
    McMeekin, Helena
    Wilhelm, Thomas
    Wagner, Thomas
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (11) : 1197 - 1205
  • [8] Testicular Metastasis of Jejunal Neuroendocrine Tumor on 68Ga-DOTATATE PET/CT
    Sahin, Omer Faruk
    Fenercioglu, Ozge Erol
    Beyhan, Ediz
    Cermik, Tevfik Fikret
    Ergul, Nurhan
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2023, 32 (02) : 156 - 158
  • [9] 68Ga-DOTATATE PET/CT Findings of Cervical Esophageal Neuroendocrine Tumor
    Filizoglu, Nuh
    Ozguven, Salih
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (07) : E393 - E394
  • [10] Primary Neuroendocrine Tumor of the Ileostomy Stoma on 68Ga-DOTATATE PET/CT
    Yu, Lei
    Braun, Alexander
    Hansen, Neil J.
    Downey, Ryan T.
    Johnson, Craig M.
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (06) : 463 - 464